Legal Opinion
Mehdi v. Karyopharm Therapeutics Inc.
District Court, D. Massachusetts
Decided July 21, 2021No. 1:19-cv-11972Unknown
1Opinion
United States District Court District of Massachusetts ) ) ) ) ) In re: Karyopharm Therapeutics ) Inc., Securities Litigation ) Civil Action No. ) 19-11972-NMG ) ) ) ) MEMORANDUM & ORDER GORTON, J. This is a putative securities fraud class action brought by lead plaintiff Dr. Myo Thant (“Dr. Thant” or “plaintiff”) on behalf of himself and other similarly situated investors against Karyopharm Therapeutics Inc. (“Karyopharm” or “defendant”) and several Karyopharm directors and executive officers (“the Individual Defendants”) (collectively, “defendants”). Dr. Thant alleges that Karyopharm…
2Cases cited28 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
- Ernst & Ernst v. HochfelderSupreme Court of the United States · 1976
- Dura Pharmaceuticals, Inc. v. BroudoSupreme Court of the United States · 2005
23 more not listed; retrieve them via the Exa API.